Close

Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. BA
7. HCP
8. SNAP
9. BSX
10. TMUS


Go back to Sarepta Therapeutics (SRPT) Shares Resume Trading; Now Up 82% on FDA Eteplirsen Approval
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 127.39 +3.14 (2.53%)
Previous Close $124.25    52 Week High $63.73 
Open $123.00    52 Week Low $8.00 
Day High $130.61    P/E N/A 
Day Low $121.80    EPS $-5.69 
Volume 1,521,189